F · Healthcare

Revive Therapeutics Ltd (31R)

Drug Manufacturers - Specialty & Generic

Revive Therapeutics Ltd (31R) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 31R

P/E ratio

18.00

Revive Therapeutics Ltd (31R) — FAQ

What is 31R's P/E ratio?

The price-to-earnings (P/E) ratio for Revive Therapeutics Ltd (31R) is 18.00 (data as of 2026-03-24).

Does Revive Therapeutics Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Revive Therapeutics Ltd (31R). Check the MyAverix Finance app for the latest dividend data.

What sector is Revive Therapeutics Ltd in?

Revive Therapeutics Ltd (31R) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 31R listed on?

31R is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)